BARIF 40 mg Tablet contains Febuxostat 40 mg, a xanthine oxidase inhibitor medicine used to reduce uric acid levels in the blood and for the long-term management of gout. (medex.com.bd)
Chronic management of gout
High uric acid levels (hyperuricemia) associated with gout
Prevention of recurrent gout attacks
Reduction of uric acid crystal formation in joints
Adults: Usually 40 mg once daily or as prescribed by a physician
Dose may be increased based on uric acid levels and medical response
Regular monitoring may be required during treatment
Nausea
Headache
Diarrhea
Skin rash
Stomach discomfort
Increased gout symptoms at the beginning of treatment